Novo Nordisk A S (NVO) stock
NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$39.43−1.27 (-3.12%)
Close on Nov 18, 2026Market cap $176.06BP/E 11.6Yield –
Novo Nordisk A S price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
No price to book ratio figures for Novo Nordisk A S
Novo Nordisk A S has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?